Toader C, Tataru C, Munteanu O, Covache-Busuioc R, Serban M, Ciurea A
Int J Mol Sci. 2025; 25(24.
PMID: 39769374
PMC: 11728275.
DOI: 10.3390/ijms252413614.
Ngwa C, Misrani A, Manyam K, Xu Y, Qi S, Sharmeen R
Transl Stroke Res. 2025; .
PMID: 39752046
DOI: 10.1007/s12975-024-01321-1.
Heneka M, van der Flier W, Jessen F, Hoozemanns J, Thal D, Boche D
Nat Rev Immunol. 2024; .
PMID: 39653749
DOI: 10.1038/s41577-024-01104-7.
Wang Y, Gao S, Cao F, Yang H, Lei F, Hou S
MedComm (2020). 2024; 5(12):e70021.
PMID: 39611043
PMC: 11604294.
DOI: 10.1002/mco2.70021.
Wijenayake S, Eisha S, Purohit M, McGowan P
Sci Rep. 2024; 14(1):28630.
PMID: 39562680
PMC: 11576889.
DOI: 10.1038/s41598-024-79724-1.
More than microglia: myeloid cells and biomarkers in neurodegeneration.
Kodosaki E, Bell R, Sogorb-Esteve A, Wiltshire K, Zetterberg H, Heslegrave A
Front Neurosci. 2024; 18:1499458.
PMID: 39544911
PMC: 11560917.
DOI: 10.3389/fnins.2024.1499458.
Escape of Kdm6a from X chromosome is detrimental to ischemic brains via IRF5 signaling.
Ngwa C, Misrani A, Manyam K, Xu Y, Qi S, Sharmeen R
Res Sq. 2024; .
PMID: 39399684
PMC: 11469404.
DOI: 10.21203/rs.3.rs-4986866/v1.
Epigenetic heterogeneity shapes the transcriptional landscape of regional microglia.
Margetts A, Vilca S, Bourgain-Guglielmetti F, Tuesta L
bioRxiv. 2024; .
PMID: 39149259
PMC: 11326298.
DOI: 10.1101/2024.08.08.607229.
Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia.
Xu K, Li Y, Zhou Y, Zhang Y, Shi Y, Zhang C
Front Cell Neurosci. 2024; 18:1429977.
PMID: 39131043
PMC: 11310010.
DOI: 10.3389/fncel.2024.1429977.
A Review on Therapeutic Strategies against Parkinson's Disease: Current Trends and Future Perspectives.
Papagiouvannis G, Theodosis-Nobelos P, Rekka E
Mini Rev Med Chem. 2024; 25(2):96-111.
PMID: 38918988
DOI: 10.2174/0113895575303788240606054620.
Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug.
Vilca S, Margetts A, Hoglund L, Fleites I, Bystrom L, Pollock T
Brain Behav Immun. 2024; 120:339-351.
PMID: 38838836
PMC: 11269013.
DOI: 10.1016/j.bbi.2024.05.038.
Neuroinflammation and the role of epigenetic-based therapies for Huntington's disease management: the new paradigm.
Temgire P, Arthur R, Kumar P
Inflammopharmacology. 2024; 32(3):1791-1804.
PMID: 38653938
DOI: 10.1007/s10787-024-01477-0.
Epigenetic regulation of microglia and neurons by proinflammatory signaling following adolescent intermittent ethanol (AIE) exposure and in human AUD.
Crews F, Macht V, Vetreno R
Adv Drug Alcohol Res. 2024; 4:12094.
PMID: 38524847
PMC: 10957664.
DOI: 10.3389/adar.2024.12094.
Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?.
Suprunowicz M, Tomaszek N, Urbaniak A, Zackiewicz K, Modzelewski S, Waszkiewicz N
Nutrients. 2024; 16(4).
PMID: 38398873
PMC: 10891846.
DOI: 10.3390/nu16040549.
DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.
Daily K, Badr A, Eltobgy M, Estfanous S, Whitham O, Tan M
Alzheimers Res Ther. 2024; 16(1):29.
PMID: 38326859
PMC: 10851453.
DOI: 10.1186/s13195-024-01390-2.
Immune-related transcriptomic and epigenetic reconfiguration in BV2 cells after lipopolysaccharide exposure: an in vitro omics integrative study.
Marroquin-Rivera A, Zhao C, Pessoni A, Bherer J, Mansouri S, Droit A
Inflamm Res. 2024; 73(2):211-225.
PMID: 38216730
DOI: 10.1007/s00011-023-01830-z.
Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug.
Vilca S, Margetts A, Fleites I, Wahlestedt C, Tuesta L
bioRxiv. 2023; .
PMID: 37961443
PMC: 10634674.
DOI: 10.1101/2023.10.19.563168.
Microglia in pediatric brain tumors: The missing link to successful immunotherapy.
du Chatinier A, Velilla I, Meel M, Hoving E, Hulleman E, Metselaar D
Cell Rep Med. 2023; 4(11):101246.
PMID: 37924816
PMC: 10694606.
DOI: 10.1016/j.xcrm.2023.101246.
Neuroimmune Interactions in Fetal Alcohol Spectrum Disorders: Potential Therapeutic Targets and Intervention Strategies.
Mukherjee S, Tarale P, Sarkar D
Cells. 2023; 12(18.
PMID: 37759545
PMC: 10528917.
DOI: 10.3390/cells12182323.
H3K27me3 of Rnf19a promotes neuroinflammatory response during Japanese encephalitis virus infection.
Zhu S, Tao M, Li Y, Wang X, Zhao Z, Liu Y
J Neuroinflammation. 2023; 20(1):168.
PMID: 37480121
PMC: 10362728.
DOI: 10.1186/s12974-023-02852-4.